PET Imaging Injection/Infusion Service System Support

Utilizing advanced encryption technology, a remote service and system support has been designed for an nuclear medicine imaging injection or infusion system.

Medrad, Inc. (Pittsburgh, PA, USA) is the first company in the United States to offer the service and can now provide remote troubleshooting capabilities and system updates for Intego through VirtualCare. The VirtualCare solution has been designed for high performance and security at every level of its architecture, offering customers the potential for faster response time and reduced downtime.

VirtualCare comes to market two years after the launch of Medrad's Intego. Since its release in 2008, Intego has been placed in hospitals and clinics throughout the United States, Europe, Australia, and the Middle East. The Intego system is loaded with a multidose vial of ¹⁸F-FDG (fluorodeoxyglucose-18-F) or ¹⁸F-NaF (sodium fluoride-18) and nuclear medicine technologists can dose on demand from a touch-screen to enable precise, flexible, safe, and efficient administration of the radiopharmaceutical. VirtualCare is the next step for Medrad to enhance service and support capabilities for the Intego positron emission tomography (PET) infusion system.

"Medrad is excited to offer the VirtualCare technology to support one of our newest and quickly growing platforms with this initial launch for Intego,” said Diane Watson, executive director of service commercialization for Medrad. "We are also looking to the future when the VirtualCare technology can be utilized to support other Medrad product platforms in radiology and cardiology around the world.”

Related Links:
Medrad